Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ammendola
Aldo Ammendola, Grafelfing DE
| Patent application number | Description | Published |
|---|---|---|
| 20090192192 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA - The present invention relates to the use of compounds as broad spectrum inhibitors of bacterial biofilm formation. In particular the invention refers to a family of compounds that block the quorum sensing system of Gram-negative and Gram-positive bacteria, a process for their manufacture, pharmaceutical compositions containing them and to their use for the treatment and prevention of bacterial damages and diseases, in particular for diseases where there is an advantage in inhibiting quorum sensing regulated phenotypes of pathogens. | 07-30-2009 |
Aldo Ammendola, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20080214635 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 09-04-2008 |
| 20090076012 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 03-19-2009 |
| 20100280034 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (XIII): | 11-04-2010 |
| 20100280036 | Modulation of Pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 11-04-2010 |
Aldo Ammendola, Muchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110105597 | Modulation of pathogenicity - The present invention relates to the use of compounds of the general Formula (I): | 05-05-2011 |
Aldo Ammendola, Graefelfing DE
| Patent application number | Description | Published |
|---|---|---|
| 20120029034 | Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents - The present invention relates to calcium salts of compounds of the general formula (I) | 02-02-2012 |
Giuseppe Ammendola, S. Giuseppe Vesuviano (na) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100075484 | SOI DEVICE WITH CONTACT TRENCHES FORMED DURING EPITAXIAL GROWING - A method for manufacturing an integrated electronic device. The method includes providing an SOI substrate having a semiconductor substrate, an insulating layer on the semiconductor substrate, and a semiconductor starting layer on the insulating layer; epitaxially growing the starting layer to obtain a semiconductor active layer on the insulating layer for integrating components of the device, and forming at least one contact trench extending from an exposed surface of the starting layer to the semiconductor substrate before the step of epitaxially growing the starting layer, wherein each contact trench clears a corresponding portion of the starting layer, of the insulating layer and of the semiconductor substrate, the epitaxial growing being further applied to the cleared portions thereby at least partially filling the at least one contact trench with semiconductor material. | 03-25-2010 |
Serena Ammendola, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20090175913 | AMMENDOLA/SALMONELLA ENTERICA STRAINS OF REDUCED PATHOGENICITY, METHOD FOR THEIR PREPARATION AND USES THEREOF - The invention concerns novel | 07-09-2009 |
Virginia Ammendola, S. Guiseppe Vesuviano (napoli) IT
| Patent application number | Description | Published |
|---|---|---|
| 20120027788 | SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF - The present invention relates to novel adenovirus strains with an improved sero-prevalence. In one aspect, the present invention relates to isolated polypeptides of adenoviral capsid proteins such as hexon, penton and fiber protein and fragments thereof and polynucleotides encoding the same. Also provided is a vector comprising the isolated polynucleotide according to the invention and adenoviruses comprising the isolated polynucleotides or polypeptides according to the invention and a pharmaceutical composition comprising said vector, adenovirus, polypeptide and/or polynucleotide. The invention also relates to the use of the isolated polynucleotides, the isolated polypeptides, the vector, the adenoviruses and/or the pharmaceutical composition for the therapy or prophylaxis of a disease. | 02-02-2012 |